J9400 Injection, ziv-aflibercept, 1mg
Also known as: ziv-aflibercept, Zaltrap
Injection of ziv-aflibercept, 1 milligram. A recombinant fusion protein targeting vascular endothelial growth factor. Angiogenesis inhibitor.
In Plain Language
blood vessel inhibitor injection; angiogenesis prevention
Clinical Context
Used for metastatic colorectal cancer resistant to standard chemotherapy. Vascular endothelial growth factor trap preventing tumor angiogenesis.
RVU Information
CPT J9400 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J9400?
CPT J9400 (Injection, ziv-aflibercept, 1mg) is a J Codes (Drugs) code. Injection of ziv-aflibercept, 1 milligram. A recombinant fusion protein targeting vascular endothelial growth factor. Angiogenesis inhibitor.
How is J9400 administered?
CPT J9400 is administered by a healthcare provider, typically via injection or infusion. Used for metastatic colorectal cancer resistant to standard chemotherapy. Vascular endothelial growth factor trap preventing tumor angiogenesis. It is used by Oncology, Gastroenterology, Surgery.
When is CPT J9400 used?
Used for metastatic colorectal cancer resistant to standard chemotherapy. Vascular endothelial growth factor trap preventing tumor angiogenesis.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.